MYCN and neoplasm: With respect to heterogeneously MYCN-amplified tumours only, the genomic background (chromosomal aberrations) of such a tumour, the reproductive advantage of the MYCN-amplified clone therein, and its disease outcome are known to be related in a counter-intuitive manner [14, 15].